RVMD

Neutral

Revolution Medicines, Inc. $RVMD Stock Holdings Lowered by First Turn Management LLC

First Turn Management LLC reduced its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 0.7% during the 4th quarter, Holdin...

watchlistnews 1 week ago 0

Bullish

Revolution Medicines, Inc. announced that it will highlight the groundbreaking results from the Phase 3 Rasolute 302 pivotal clinical trial of Daraxonrasib in previously treated patients with metastatic pancreatic cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Revolution Medicines, Inc. is set to present breakthrough findings from its Phase 3 Rasolute 302 clinical trial of Daraxonrasib at the ASCO Annual Mee...

Bitget 3 weeks ago 0